Spero Therapeutics is actively pursuing collaborations with partners for scientific expertise and funding support.
Stock information, SEC filings, corporate governance, IR resources and more.
Collaborative. Exciting. Challenging. Stimulating. Committed. Spero Therapeutics was founded in 2013.
Led by an executive team with deep experience and world-class scientific talent, Spero is dedicated to delivering differentiated medicines that help patients suffering from serious and life-threatening infections.